Gilead Sciences Inc (NASDAQ:GILD)
| 70.43 Delayed Data As of Jan 18 |  -1.34 / -1.87%Today’s Change | 61.39 Today|||52-Week Range 74.12 | -3.00% Year-to-Date |
Latest GILD News | Press Releases
Today’s Trading
| Previous close | 71.77 |
| Today’s open | 71.42 |
| Day’s range | 70.07 - 71.52 |
| Volume | 8,987,261 |
| Average volume (3 months) | 6,992,944 |
| Market cap | $90.0B |
Data as of 4:14pm ET, 01/18/2022
Growth & Valuation
| Earnings growth (last year) | -97.69% |
| Earnings growth (this year) | +14.21% |
| Earnings growth (next 5 years) | +1.10% |
| Revenue growth (last year) | +10.39% |
| P/E ratio | 12.0 |
| Price/Sales | 2.99 |
| Price/Book | 4.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNAModerna Inc | -18.12 | -8.85% |
| ILMNIllumina Inc | -22.01 | -5.43% |
| AMGNAmgen | -1.53 | -0.65% |
| BIIBBiogen | -5.49 | -2.29% |
Data as of 5:47pm ET, 01/18/2022
Financials
| Next reporting date | February 8, 2022 |
| EPS forecast (this quarter) | $1.53 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $123.0M |
| Net profit margin | 0.50% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
